Great Analysis
@malkazoid you connected with me own thoughts in your commentary.
Now... just imagine for a moment that IHL was an infant just trying to find it's feet and within it's own family it had a big brother that was all grown up. That everyone looked up to and was doing great things....his/her name would be GW Pharmaceuticals PLC..GW is the global leader in developing cannabinoid-based medicines
click the link to go to their website. Overnight big brother GW has received a big offer...
GW has gone from $146.25 (US) per share to $211.65 on the back of a take-over - merger offer from BIG PHARMA
Under the terms of the deal, Jazz Pharma will pay $200 per share in cash and $20 in stock for each share owned, or a premium of about 50% over GW's closing price on Tuesday, and 60% over its 30-day volume weighted average price. The deal is expected to close in the second quarter, to boost profit in the first year after close and to drive double-digit revenue growth. GW is a leader in therapies based on its proprietary cannabinoid product platform to treat a number of diseases. The company was the first to receive FDA approval for a CBD-based treatment for severe forms of childhood epilepsy in its Epidiolex lead product. Jazz makes sleep medications and has a growing oncology business. GW Pharma shares soared 46% premarket after resuming trade following a halt for the news. Jazz shares were down 2.7% premarket, but have gained 11% in the last 12 months, while the S&P 500 SPX, 0.37% has gained 18%.
READ MORE HERE